日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Acute side effects of proton and photon radiotherapy for medulloblastoma: a retrospective national multicenter study

质子和光子放射疗法治疗髓母细胞瘤的急性副作用:一项回顾性全国多中心研究

Diaz, Linn Söderlund; Agrup, Måns; Asklid, Anna; Embring, Anna; Engellau, Jacob; Kristensen, Ingrid Fagerström; Flejmer, Anna; Fröjd, Charlotta; Nilsson, Martin P; Svärd, Anna Maja; Walfridsson, Angelica; Blomstrand, Malin

Correction to: Acute side effects of proton and photon radiotherapy for medulloblastoma: a retrospective national multicenter study

更正:质子和光子放射疗法治疗髓母细胞瘤的急性副作用:一项回顾性全国多中心研究

Diaz, Linn Söderlund; Agrup, Måns; Asklid, Anna; Embring, Anna; Engellau, Jacob; Kristensen, Ingrid Fagerström; Flejmer, Anna; Fröjd, Charlotta; Nilsson, Martin P; Svärd, Anna Maja; Walfridsson, Angelica; Blomstrand, Malin

Risk Factors in Elective Colon Surgery for the Elderly: A Retrospective Cohort Analysis From the Swedish Part of the International ERAS Database

老年人择期结肠手术的风险因素:来自国际ERAS数据库瑞典部分的回顾性队列分析

Bjerregaard, Felix; Baloch, Naseer; Asklid, Daniel; Ljungqvist, Olle; Pekkari, Klas; Elliot, Anders H; Gustafsson, Ulf O

Comparative proton and photon treatment plans in children treated for neuroblastoma

儿童神经母细胞瘤治疗中质子和光子治疗方案的比较

Embring, Anna; Kristensen, Ingrid; Nilsson, Martin P; Engellau, Jacob; Blomstrand, Malin; Fröjd, Charlotta; Agrup, Måns; Flejmer, Anna; Svärd, Anna-Maja; Asklid, Anna

Why are not all paediatric cancer patients treated with protons? A population-based report from Sweden, 2016-2023

为什么并非所有儿童癌症患者都接受质子治疗?瑞典2016-2023年基于人群的报告

Asklid, Anna; Kristensen, Ingrid; Martinsson, Ulla; Nilsson, Martin; Blomstrand, Malin; Agrup, Måns; Flejmer, Anna; Svärd, Anna-Maja; Fröjd, Charlotta; Almhagen, Erik; Engellau, Jacob; Embring, Anna

Short-term outcome in robotic vs laparoscopic and open rectal tumor surgery within an ERAS protocol: a retrospective cohort study from the Swedish ERAS database

在ERAS方案下,机器人辅助直肠肿瘤手术与腹腔镜手术和开放式直肠肿瘤手术的短期疗效比较:一项基于瑞典ERAS数据库的回顾性队列研究

Asklid, Daniel; Ljungqvist, Olle; Xu, Yin; Gustafsson, Ulf O

Risk-adapted bendamustine + rituximab is a tolerable treatment alternative for elderly patients with chronic lymphocytic leukaemia: a regional real-world report on 141 consecutive Swedish patients

风险适应性苯达莫司汀联合利妥昔单抗治疗方案是老年慢性淋巴细胞白血病患者一种耐受性良好的治疗选择:一项纳入141例瑞典连续患者的区域性真实世界研究报告

Mattsson, Agnes; Sylvan, Sandra E; Asklid, Anna; Wiggh, Joel; Winqvist, Maria; Lundin, Jeanette; Mansouri, Larry; Rosenquist, Richard; Johansson, Hemming; Österborg, Anders; Hansson, Lotta

First-line therapy in chronic lymphocytic leukemia: a Swedish nation-wide real-world study on 1053 consecutive patients treated between 2007 and 2013

慢性淋巴细胞白血病的一线治疗:一项瑞典全国性真实世界研究,纳入了2007年至2013年间接受治疗的1053例连续患者

Sylvan, Sandra Eketorp; Asklid, Anna; Johansson, Hemming; Klintman, Jenny; Bjellvi, Jenny; Tolvgård, Staffan; Kimby, Eva; Norin, Stefan; Andersson, Per-Ola; Karlsson, Claes; Karlsson, Karin; Lauri, Birgitta; Mattsson, Mattias; Sandstedt, Anna Bergendahl; Strandberg, Maria; Österborg, Anders; Hansson, Lotta

Long-term real-world results of ibrutinib therapy in patients with relapsed or refractory chronic lymphocytic leukemia: 30-month follow up of the Swedish compassionate use cohort

伊布替尼治疗复发或难治性慢性淋巴细胞白血病患者的长期真实世界结果:瑞典同情用药队列的30个月随访

Winqvist, Maria; Andersson, Per-Ola; Asklid, Anna; Karlsson, Karin; Karlsson, Claes; Lauri, Birgitta; Lundin, Jeanette; Mattsson, Mattias; Norin, Stefan; Sandstedt, Anna; Rosenquist, Richard; Späth, Florentin; Hansson, Lotta; Österborg, Anders

Ibrutinib versus previous standard of care: an adjusted comparison in patients with relapsed/refractory chronic lymphocytic leukaemia

伊布替尼与既往标准治疗:复发/难治性慢性淋巴细胞白血病患者的调整后比较

Hansson, Lotta; Asklid, Anna; Diels, Joris; Eketorp-Sylvan, Sandra; Repits, Johanna; Søltoft, Frans; Jäger, Ulrich; Österborg, Anders